
NIH launches study into long-term health effects of East Palestine train disaster; ACC issues guidance on weight management drugs; eating more produce linked to better sleep – Morning Medical Update
Key Takeaways
- NIH's $10 million study will assess long-term health impacts of the East Palestine train derailment, focusing on chemical exposures like vinyl chloride and benzene.
- ACC's new guidance recommends GLP-1 and GIP-based weight-loss medications as first-line treatments for cardiovascular patients with obesity, shifting from "lifestyle-first" models.
The top news stories in medicine today.
At the urging of Vice President JD Vance, the
The American College of Cardiology (ACC) has released new clinical guidance recommending GLP-1 and GIP-based weight-loss medications, like semaglutide and tirzepatide, as first-line treatments for cardiovascular patients with obesity. The guidance marks a shift from prior “lifestyle-first” models, citing strong evidence that these medications reduce major cardiovascular events in high-risk patients. Published in
A new study from the
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.
















